Bortezomib Provides Effective Therapy for Antibody- and Cell-Mediated Acute Rejection
Bortezomib Provides Effective Therapy for Antibody- and Cell-Mediated Acute Rejection is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Bortezomib Provides Effective Therapy for Antibody- and Cell-Mediated Acute Rejection have?
Bortezomib Provides Effective Therapy for Antibody- and Cell-Mediated Acute Rejection has 390 citations in the OpenAlex counts ScholarIQ stores.
When was Bortezomib Provides Effective Therapy for Antibody- and Cell-Mediated Acute Rejection published?
Bortezomib Provides Effective Therapy for Antibody- and Cell-Mediated Acute Rejection has 2008 year in the ScholarIQ index.
What is the open-access status of Bortezomib Provides Effective Therapy for Antibody- and Cell-Mediated Acute Rejection?
Bortezomib Provides Effective Therapy for Antibody- and Cell-Mediated Acute Rejection has closed oa status in the ScholarIQ index.
What is the DOI of Bortezomib Provides Effective Therapy for Antibody- and Cell-Mediated Acute Rejection?
The DOI for Bortezomib Provides Effective Therapy for Antibody- and Cell-Mediated Acute Rejection is on the source record.
What is the PMID of Bortezomib Provides Effective Therapy for Antibody- and Cell-Mediated Acute Rejection?
The PMID for Bortezomib Provides Effective Therapy for Antibody- and Cell-Mediated Acute Rejection is on the source record.
What is the OpenAlex record for Bortezomib Provides Effective Therapy for Antibody- and Cell-Mediated Acute Rejection?
The OpenAlex for Bortezomib Provides Effective Therapy for Antibody- and Cell-Mediated Acute Rejection is on the source record.